Form 4 for REVB REVELATION BIOSCIENCES, INC.
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-10 · accession 0001376474-22-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-01-11 | 2022-01-10 | REVB | Feis Lawrence | 10% | J - Other | $10.20 | -732.0K | 0 | -100% | -$7.47M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | J | D | 731,950 | $10.20 | 0 | I See Footnote 2. | — | — | (F2) The Common Stock is directly owed by Feis Equities LLC. Lawrence Feis, as the Managing Member of Feis Equities LLC will also be deemed to beneficially own the shares. |